Mr. Speaker, the second petition with many signatures that I have the privilege to table today is one that is addressing the failed access to medicine regime that was put in place two and a half years ago, supposedly intended to allow drug companies in Canada to produce and export cheaper versions of brand name drugs to developing countries where people are suffering with HIV-AIDS. Yet not a single pill has flowed from that supposed Chrétien legacy bill.
Therefore, the petitioners are urging the government to reform that law and to review the obstacles in the legislation preventing the drugs going to those who most desperately need them in developing countries, particularly sub-Saharan Africa